Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Wen Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3247-9672; OpenAlex author ID A5100444383. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer. Co-author DOI 10.1186/s12885-025-13799-5↗
  2. A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer. Co-author DOI 10.12659/msm.927654↗
  3. Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial. Co-author DOI 10.1007/s00280-018-3650-4↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Biyang Cao · 1 shared paper, 2025 · strength 0.22
  2. Letian Zhang · 1 shared paper, 2025 · strength 0.22
  3. Wenwei Yang · 1 shared paper, 2025 · strength 0.22
  4. Xiaoting Ma · 1 shared paper, 2025 · strength 0.22
  5. Kai Ou · 1 shared paper, 2025 · strength 0.22
  6. Lin Yang · 1 shared paper, 2025 · strength 0.22
  7. Aiping Zhou · 2 shared papers, 2018–2020 · strength 0.19
  8. Hanzhi Cui · 1 shared paper, 2020 · strength 0.11
  9. Jun Zhou · 1 shared paper, 2020 · strength 0.11
  10. Guochao Deng · 1 shared paper, 2020 · strength 0.11
  11. Changjie Lou · 1 shared paper, 2020 · strength 0.11
  12. Yanqiao Zhang · 1 shared paper, 2020 · strength 0.11
  13. Guanghai Dai · 1 shared paper, 2020 · strength 0.11
  14. Yongkun Sun · 1 shared paper, 2018 · strength 0.08
  15. Chengfeng Wang · 1 shared paper, 2018 · strength 0.08
  16. Chunxia Du · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.